Clinical Applications of Stem Cells

Overview

The Singapore Bioimaging Consortium and Select Biosciences South East Asia present the Clinical Applications of Stem Cells.  

Having successfully run an allied event for the last two years in Palm Desert, California, USA, we look forward to bringing the subject matter to Singapore. 

We are pleased to welcome Dr. Larry Stanton, Senior Group Leader/Associate Director, Stem Cell and Regenerative Biology, Genome Institute of Singapore as our Conference Chairman. 

We aim to bring together researchers and clinicians focusing on translating basic discoveries in the stem cells field into applications for regenerative medicine and cellular therapy. We will also be looking specifically into how the global regulatory agencies view the translational efforts. 

The meeting will run over two full days, with presentations from clinicians, regulatory bodies, academia and industry, leading into panel discussions each afternoon to cover the points raised during the earlier sessions. 

Attending this conference will provide you with a detailed overview of the current research, clinical practices and regulatory requirements in this rapidly developing field. 

Select Biosciences and the Organising Committee is looking forward to welcoming you to the event.  

Organising Committee 

Lawrence Stanton, Senior Group Leader/Associate Director, Stem Cell and Regenerative Biology, Genome Institute of Singapore  

Shigeki Sugii, Group Leader/Assistant Professor, Singapore Bioimaging Consortium/Duke NUS Graduate Medical School 

Teck Sin Lim, Founder, Adigenics

Selected Papers from the Clinical Applications of Stem Cells

The Journal of Clinical Medicine is an international, peer-reviewed open access journal.

As a journal partner for the Clinical Applications of Stem Cells, JCM will produce a special issue entitled "Selected Papers from the Clinical Applications of Stem Cells" and publish the perspectives and research results presented in the conference.

The Guest Editor for the special issue will be the Conference Chairman, Dr. Larry Stanton, Senior Group Leader/Associate Director, Stem Cell and Regenerative Biology, Genome Institute of Singapore.

The journal provides a platform for discussing advances in health care/clinical practices, for the study of direct observation of patients, and for general medical research.

There is no limit to publication length: the aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Because it is an open access journal, papers published will receive high publicity. JCM is a member of the Committee on Publication Ethics (COPE). While the current list of Editorial Board members can be found at:

Editorial Board Members